Vaxxa AB (NGM:VAXXA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.5100
-0.0100 (-1.92%)
At close: May 29, 2026

Vaxxa AB Revenue

Vaxxa AB had revenue of 18.24M SEK in the quarter ending March 31, 2026, with 42.52% growth. This brings the company's revenue in the last twelve months to 82.89M, up 8.97% year-over-year. In the year 2025, Vaxxa AB had annual revenue of 77.45M, down -8.01%.

Revenue (ttm)
82.89M
Revenue Growth
+8.97%
P/S Ratio
0.27
Revenue / Employee
10.36M
Employees
8
Market Cap
22.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202577.45M-6.74M-8.01%
Dec 31, 202484.19M30.61M57.14%
Dec 31, 202353.58M--
Dec 31, 2022---
Dec 31, 20214.75M4.15M690.54%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jumpgate AB40.94M
Level Bio AB33.55M
Qbrick AB31.13M
Transiro Holding AB27.89M
edyoutec AB17.05M
Hybricon AB16.15M
LightAir AB14.43M
Holdflight AB6.90M
Revenue Rankings

Vaxxa AB News

More News